News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aerocrine Launches a New Fully Portable Hand-Held Device to Measure Airway Inflammation in Asthma



9/11/2013 9:39:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B)(OMX Nordic Exchange: AERO) is pleased to announce the launch of NIOX VERO®, a new, fully portable hand-held point-of-care device for the measurement of airway inflammation, such as asthma. Aerocrine introduces the new device in conjunction with the European Respiratory Society (ERS) annual meeting in Barcelona, September 7-11, 2013. NIOX VERO® was developed in collaboration between Aerocrine and Panasonic Healthcare Co.,Ltd.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Aerocrine
 
 
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES